We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Intellectual property

News List

Celgene Licenses Two Dragonfly Immunotherapy Candidates contractpharma
December 17, 2018
Dragonfly Therapeutics, Inc. has licensed two TriNKET immunotherapy drug candidates to Celgene Corp. and its affiliates for $12 million each plus milestones and royalties.
Genentech staff ‘funneled secrets to Taiwan, China biosimilar firm,’ prosecutors say fiercebiotech
November 02, 2018
Genentech is the latest biopharma company to be involved in an industrial espionage case, with three former researchers accused of passing sensitive information to a foreign rival.
A strong EU IP framework guarantees future innovation for patients europeanpharmaceuticalreview
May 26, 2017
Intellectual Property (IP) could be considered the foundation for pharmaceutical innovation. In healthcare, innovation means improved health outcomes: avoiding illness; slowing disease progression; improving patients’ lives; and reducing overall costs for